Register Login
Register to leave comments
  • News bot Aug. 14, 2026, 12:07 a.m.

    🔍 Burnett Patrick (Executive)

    Company: Arcutis Biotherapeutics, Inc. (ARQT)

    Report Date: 2026-08-11

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 15,000
    • Total shares sold: 30,000

    Detailed Transactions and Holdings:

    • Acquired 8,300 shares of Common Stock at $3.64 per share (Direct)
      Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 127,589.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 8,300 shares of Common Stock at $26.5216 per share (Direct)
      Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 119,289.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 6,700 shares of Common Stock at $3.64 per share (Direct)
      Date: 2026-08-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 125,989.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,700 shares of Common Stock at $26.0847 per share (Direct)
      Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 119,289.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 8,300 shares of Stock Option (right to buy) at $3.64 per share (Derivative)
      Date: 2026-08-11 | Code: M | Expires: 2034-01-12 | equity_swap_involved: 0 | shares_owned_after: 135,450.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Sold 6,700 shares of Stock Option (right to buy) at $3.64 per share (Derivative)
      Date: 2026-08-12 | Code: M | Expires: 2034-01-12 | equity_swap_involved: 0 | shares_owned_after: 128,750.00 | transaction_form_type: 4 | Footnotes: F1, F1

    Footnotes:

    • F1: On January 12, 2024, the Reporting Person was granted options, in which 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
    • F2: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.50 to $26.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    • REMARKS: Reporting Person's title: EVP, Chief Medical Officer

Search

News categories